SCHEMBL215859

SCHEMBL215859

Cc1ccc(Br)cc1NC(=O)c1nc[nH]c1C(=O)Nc1nc2cccc(OC3CCNCC3)c2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 9/20 0.42
HSP90AB1 P08238 6/20 0.42
ALDH1A1 P00352 6/20 0.40
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2735383 1.00 TOP2A (0.42) TOP2AHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL13300431 0.92 TOP2A (0.40) TOP2AHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL216162 0.91 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1HPGDCYP1A2
SCHEMBL213406 0.87 TOP2A (0.44) TOP2AALDH1A1KMT2AMEN1MAPT
SCHEMBL3984920 0.85 IDO1 (0.35) TOP2AALDH1A1KMT2AMEN1HPGD
SCHEMBL4109979 0.85 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1HPGDCYP1A2
SCHEMBL2735449 0.85 ALDH1A1 (0.41) TOP2AHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL214824 0.85 ALDH1A1 (0.41) TOP2AHSP90AB1ALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL213801 0.84 ALDH1A1 (0.40) TOP2AHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL2735386 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088767-B2 JAK-2 modulators and methods of use EXELIXIS, INC. (US) 2012-01-03 US disclosed
US-8088767-B2 JAK-2 modulators and methods of use EXELIXIS, INC. (US) 2012-01-03 US disclosed
US-8088767-B2 JAK-2 modulators and methods of use EXELIXIS, INC. (US) 2012-01-03 US disclosed
EP-2061768-A2 IMIDAZOLE-4,5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS Exelixis, Inc. (US) 2009-05-27 EP disclosed
WO-2008042282-A2 IMIDAZOLE-4, 5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS EXELIXIS, INC. (US) 2008-04-10 WO disclosed
WO-2008042282-A2 IMIDAZOLE-4, 5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS EXELIXIS, INC. (US) 2008-04-10 WO disclosed